NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
16.22
Dollar change
+0.51
Percentage change
3.25
%
Index- P/E- EPS (ttm)-4.27 Insider Own0.42% Shs Outstand20.72M Perf Week28.73%
Market Cap336.08M Forward P/E- EPS next Y-1.24 Insider Trans0.00% Shs Float20.63M Perf Month38.87%
Enterprise Value61.93M PEG- EPS next Q-0.25 Inst Own17.70% Short Float2.08% Perf Quarter84.23%
Income-87.79M P/S1.57 EPS this Y46.42% Inst Trans1.37% Short Ratio3.53 Perf Half Y77.58%
Sales214.21M P/B0.71 EPS next Y42.15% ROA-12.15% Short Interest0.43M Perf YTD67.22%
Book/sh22.86 P/C1.19 EPS next 5Y39.37% ROE-17.22% 52W High17.18 -5.59% Perf Year16.16%
Cash/sh13.61 P/FCF- EPS past 3/5Y- -24.69% ROIC-18.23% 52W Low7.08 129.10% Perf 3Y-59.25%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-26.80% -11.92% Gross Margin33.62% Volatility9.63% 7.14% Perf 5Y-88.64%
Dividend TTM- EV/Sales0.29 EPS Y/Y TTM-65.68% Oper. Margin-44.26% ATR (14)1.00 Perf 10Y-65.64%
Dividend Ex-Date- Quick Ratio2.55 Sales Y/Y TTM-22.93% Profit Margin-40.99% RSI (14)73.72 Recom4.33
Dividend Gr. 3/5Y- - Current Ratio3.53 EPS Q/Q-57.14% SMA2019.73% Beta0.81 Target Price10.50
Payout- Debt/Eq0.02 Sales Q/Q-25.33% SMA5037.37% Rel Volume1.40 Prev Close15.71
Employees275 LT Debt/Eq0.02 EarningsMay 07 BMO SMA20048.59% Avg Volume121.75K Price16.22
IPOApr 01, 1993 Option/ShortYes / Yes EPS/Sales Surpr.94.81% -19.14% Trades Volume170,121 Change3.25%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Underweight
Oct-25-23Downgrade Jefferies Buy → Hold $3 → $1
Jan-06-23Upgrade Jefferies Hold → Buy $1.30 → $3
May-06-22Downgrade JP Morgan Neutral → Underweight
May-05-22Downgrade SVB Leerink Outperform → Mkt Perform $10 → $3
May-05-22Downgrade H.C. Wainwright Buy → Neutral $10 → $3
May-04-22Downgrade Northland Capital Outperform → Market Perform
May-12-21Downgrade Goldman Neutral → Sell $6 → $5
Sep-29-20Resumed JP Morgan Neutral
Aug-26-20Initiated Piper Sandler Overweight $21
Jun-27-25 10:00AM
Jun-25-25 11:06AM
10:02AM
09:28AM
Jun-24-25 07:05AM
07:00AM Loading…
07:00AM
Jun-23-25 12:34PM
Jun-20-25 09:46AM
Jun-19-25 11:11AM
Jun-18-25 10:51AM
Jun-16-25 09:55AM
09:40AM
Jun-10-25 12:00PM
10:00AM
09:08AM
06:50AM Loading…
06:50AM
Jun-06-25 11:52AM
Jun-05-25 01:03PM
12:55PM
Jun-04-25 12:17PM
10:46AM
Jun-03-25 11:14AM
09:43AM
Jun-02-25 11:58AM
May-30-25 08:59AM
May-29-25 11:53AM
11:44AM
10:50AM
09:40AM
May-28-25 11:09AM
11:07AM Loading…
11:07AM
10:43AM
May-27-25 10:46AM
May-26-25 11:44AM
11:25AM
May-23-25 10:01AM
09:57AM
May-21-25 12:33PM
09:50AM
May-20-25 11:50AM
May-08-25 12:07PM
03:07AM
May-07-25 11:01AM
07:32AM
07:00AM
May-03-25 03:02AM
Apr-29-25 04:15PM
Apr-28-25 04:15PM
Apr-09-25 07:30AM
Apr-07-25 07:30AM
Mar-31-25 08:00AM
Mar-19-25 12:45PM
07:30AM
Mar-13-25 03:02AM
Mar-12-25 12:45PM
07:20AM
07:01AM
07:00AM
Feb-27-25 09:00AM
Feb-25-25 08:00AM
Feb-19-25 08:30AM
Dec-16-24 07:00AM
Dec-13-24 09:00AM
Nov-19-24 09:35AM
Nov-11-24 08:00AM
Nov-01-24 03:19AM
Oct-31-24 02:00AM
Oct-30-24 05:21PM
04:05PM
Oct-29-24 09:16AM
Oct-09-24 03:32PM
Oct-01-24 08:00AM
Sep-09-24 07:30AM
Aug-22-24 08:30AM
Aug-01-24 12:59PM
Jul-31-24 02:15PM
07:00AM
Jul-29-24 02:26PM
Jul-17-24 04:15PM
08:00AM
Jul-08-24 07:30AM
Jun-04-24 07:30AM
May-28-24 08:15AM
May-06-24 08:00AM
May-03-24 10:16AM
09:40AM
May-01-24 12:35PM
11:54AM
11:00AM
08:35AM
07:30AM
07:00AM
Apr-24-24 02:00PM
Apr-22-24 08:00AM
Apr-15-24 08:00AM
Apr-08-24 08:00AM
06:30AM
Apr-06-24 03:30PM
Apr-04-24 01:20PM
Apr-03-24 04:13PM
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Berg AaronPresident and CEOAug 02 '24Buy0.64160,000102,400805,380Aug 05 05:30 PM